Etiological factors in the development of the disease
The development of secondary non-infectious interstitial nephritis is always secondary to a pre-existing pathological background. The main causes can be divided into two large groups:
- Complication of systemic pathologies. The disease often manifests against the background of pronounced metabolic or systemic disorders. Leading causes include diabetes mellitus, multiple myeloma, gout, and nephrocalcinosis. In these conditions, the renal interstitium is damaged by endogenous metabolic products.
- Drug-induced (toxic) injury. A critical risk factor is the prolonged, often uncontrolled use of nonsteroidal anti-inflammatory drugs (NSAIDs). In clinical practice, this condition is referred to as analgesic nephropathy. The toxic effect of medications leads to chronic abacterial inflammation of the interstitial tissue.
Clinical presentation and masking as pyelonephritis
The complexity of diagnosis lies in the significant clinical similarity between secondary interstitial nephritis and bacterial pyelonephritis. Patients often present with complaints traditionally associated with a urinary tract infection.
Patients may experience pronounced fever and severe chills. A characteristic symptom is lower back pain of varying severity. In addition, the clinical picture often records a persistent increase in blood pressure (arterial hypertension), indicating involvement of the renal parenchyma and impaired regulation of vascular tone.
Differential diagnosis with pyelonephritis
Despite superficial similarities, there are a number of clear criteria that distinguish abacterial interstitial nephritis from pyelonephritis.
- Edematous syndrome: in secondary interstitial nephritis, edema is entirely uncharacteristic and absent.
- Urinary syndrome: the earliest and most specific sign is polyuria (an increase in urine output). Urinalysis, in addition to standard proteinuria, consistently reveals microhematuria (red blood cells) and cylindruria.
- Bacteriological examination: since the nature of the inflammation is initially abacterial, true bacteriuria in urine cultures is extremely rare.
- Radiological presentation: unlike chronic pyelonephritis, instrumental examination shows no characteristic deformations or changes in the renal calyx and pelvis system.
Principles of therapeutic management
Treatment measures for this disease are based on a combination of etiotropic and pathogenetic approaches aimed at eliminating the cause and restoring organ function.
Etiotropic therapy involves prescribing repeated courses of antibacterial drugs. A critical condition is that the choice of a specific antibiotic must be strictly individualized—strictly depending on the identified microflora (if secondary infection is added) and the results of susceptibility testing.
Pathogenetic therapy is based on mandatory surgical or conservative correction of any anatomical defects and causes that disrupt urodynamics. The main task of this stage is the complete restoration of adequate urine flow through the urinary tract.
Briefly: answers to topical questions
What is the mechanism of renal interstitial damage in multiple myeloma?
The main pathogenetic mechanism is damage to nephron structures by monoclonal immunoglobulin light chains (Bence Jones protein). Under conditions of overflow proteinuria, the amount of these low-molecular-weight proteins exceeds the reabsorption capacity of the tubules, triggering the following mechanisms of nephrotoxicity:
- Direct toxic effect — some light chains prove directly toxic to renal tubular epithelial cells.
- Cast formation — in an acidic environment, the Bence Jones protein binds to the urinary glycoprotein (Tamm-Horsfall protein), leading to the formation of large histological tubular casts and obstruction (myeloma cast nephropathy).
For differential diagnosis with pyelonephritis, use the "Four NOs" rule: NO edema, NO bacteria (abacterial), NO pelvic deformation on X-ray, NO oliguria (instead — early polyuria).
Class and exam questions
An early sign of secondary interstitial nephritis is polyuria — an increase in the daily volume of excreted urine.
An early sign of secondary interstitial nephritis is polyuria — an increase in the daily volume of excreted urine, later joined by microhematuria and proteinuria.
How to distinguish this disease from pyelonephritis based on X-ray results?
In secondary non-infectious interstitial nephritis, radiographs show no structural deformations of the renal pelvis characteristic of pyelonephritis.
What is analgesic nephropathy?
This is a form of secondary interstitial nephritis that develops as a consequence of toxic kidney injury due to the prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs).
What else to study on this topic
- Pathogenesis of renal injury in gout (urate nephropathy)
- Mechanisms of myeloma kidney development
- Urodynamic features and methods of its surgical restoration
- Criteria for selecting antibacterial drugs considering flora susceptibility
- The impact of diabetes mellitus on the renal tubulointerstitial tissue
Master the entire topic in the "Propaedeutics" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Secondary interstitial nephritis" and 3,152 other pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 113 video lessons on the subject
Other topics in the "Urinary System" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.